+86-0635-6175299

Company Details

Shandong Haohong Biotechnology Co., Ltd.

[Shandong,China]

Business Type:Manufacturer

Main Markets: Americas , Asia , East Europe , Europe , Middle East , North Europe , West Europe , Worldwide

Exporter:71% - 80%

Certs:Test Report, ISO9001
Language

Shandong Haohong Biotechnology Co., Ltd.

 HomeNewsSupply of High-quality Bicalutamide Intermediates

Supply of High-quality Bicalutamide Intermediates

2021-06-29

Shandong Haohong Biotechnology Co., Ltd is mainly focuses on the development of anti-cancer, anti-diabets series of API and its advanced intermediates. The main products include Bicalutamide, enzalutamide, apalutamide, macitentan, cabozantinib, ceritinib, empagliflozin, tofacitinib citrate, and alectinib,etc. In line with the concept of "truth-seeking, innovation and integrity", we had exported our products to the United States, European countries, Japan, India, Bangladesh and other overseas markets. At present, Our company has dozens of advanced intermediates, all of which are commercialized.

Bicalutamide is a non steroidal androgen antagonist, competing with androgen for androgen receptor, blocking cell uptake of androgen and inhibiting the binding of androgen with target organs. After binding with chemical Book androgen receptor, bicalutamide forms receptor complex and enters the cell nucleus to bind with nuclear protein, thus inhibiting the growth of tumor cells; It can be used as the first line of palliative treatment for advanced prostate cancer.

Bicalutamide Intermediates has always been one of the main products promoted by our company.The products purity is at least 99%.Our company always pays attention to product quality and strictly controls quality.

If you want to know more information about our company and products, please visit our website at http://www.haohongpharma.com. We will offer the best price and the best quality for you.

cas 654-70-6

Previous: Supply of high-quality Cabozantinib API and Intermediates

Next: Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics License Application for the Treatment of Recurrent or Metastatic Cervical Cancer

 HomeNewsSupply of High-quality Bicalutamide Intermediates

Shandong Haohong Biotechnology Co., Ltd.